Abstract
Aims/hypothesisStudies investigating associations between kynurenines and cognitive function have generally been small, restricted to clinical samples or have found inconsistent results, and associations in the general adult population, and in individuals with type 2 diabetes in particular, are not clear. Therefore, the aim of the present study was to investigate cross-sectional associations between plasma kynurenines and cognitive function in a cohort of middle-aged participants with normal glucose metabolism, prediabetes (defined as impaired fasting glucose and/or impaired glucose tolerance) and type 2 diabetes.MethodsPlasma kynurenines were quantified in 2358 participants aged 61 ± 8 years. Cross-sectional associations of kynurenines with cognitive impairment and cognitive domain scores were investigated using logistic, multiple linear and restricted cubic spline regression analyses adjusted for several confounders.ResultsEffect modification by glucose metabolism status was found for several associations with cognitive impairment, hence analyses were stratified. In individuals with prediabetes, 3-hydroxykynurenine (OR per SD 0.59 [95% CI 0.37, 0.94]) and 3-hydroxyanthranilic acid (0.67 [0.47, 0.96]) were associated with lower odds of cognitive impairment after full adjustment. In individuals with type 2 diabetes, kynurenine (0.80 [0.66, 0.98]), 3-hydroxykynurenine (0.82 [0.68, 0.99]), kynurenic acid (0.81 [0.68, 0.96]), xanthurenic acid (0.73 [0.61, 0.87]) and 3-hydroxyanthranilic acid (0.73 [0.60, 0.87]) were all associated with lower odds of cognitive impairment. Kynurenic acid (β per SD 0.07 [95% CI 0.02, 0.13]) and xanthurenic acid (0.06 [0.01, 0.11]) were also associated with better executive function/attention. No associations were observed in individuals with normal glucose metabolism.Conclusions/interpretationSeveral kynurenines were cross-sectionally associated with lower odds of cognitive impairment and better cognitive functioning in type 2 diabetes, while less widespread associations were seen in prediabetes. Low levels of kynurenines might be involved in the pathway of type 2 diabetes and cognitive decline but this needs further studies.Graphical abstract
Highlights
Individuals with type 2 diabetes often show impairment in cognitive functions [1] and have a 60% higher risk of developing dementia [2]
Previous studies that have focused on clinical samples of patients with cognitive impairment and dementia have often reported an imbalance in neurotoxic-toneuroprotective metabolites [13,14,15,16,17], and one prospective study has found an association between elevated levels of anthranilic acid (AA) and risk for dementia and Alzheimer’s disease dementia [18]
The present study aims to elucidate the associations between a comprehensive panel of plasma kynurenines and cognitive function in a cohort of middleaged individuals. Since both dysregulations of the KYN metabolic pathway and a higher risk of dementia have been found in type 2 diabetes [2, 10], we investigate whether these associations are modified by glucose metabolism status
Summary
Individuals with type 2 diabetes often show impairment in cognitive functions [1] and have a 60% higher risk of developing dementia [2]. Individuals with type 2 diabetes show early pathophysiological changes associated with cognitive decline and dementia, including microvascular changes and neurodegeneration [4, 5]. These changes can be found as early as the prediabetic stage [6, 7]. In a recent population-based study in healthy older adults, no associations between concentrations of kynurenines and cognitive test scores were found [19]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
